Curanail

Quick links to important sections

Curanail

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Curanail

Property Description
Active ingredient Amorolfine
Form Medicated nail lacquer (Topical Solution)
Pharmacological class Antifungal agent (Antimycotic)
Common use Fungal nail infections (Onychomycosis)
Origin Synthetic (Morpholine derivative)

What is Curanail and What is its Purpose?

Curanail is a brand name for a synthetic, broad-spectrum antifungal agent whose general purpose is the management of persistent fungal infections affecting the fingernails and toenails, known as onychomycosis. It contains the single active ingredient Amorolfine and belongs to the chemically distinct class of morpholine derivatives. This specialized classification establishes the drug's fundamental identity as a product designed for dermatological use against fungal pathogens.

Clinical assessments of Amorolfine affirm its role in treating fungal nail infections, indicating that the medicine is consistently recognized as an effective option for clearing fungal growth.


Composition and Drug Form: Amorolfine Nail Lacquer

The active pharmaceutical ingredient in Curanail is Amorolfine, typically formulated as Amorolfine hydrochloride. This single active ingredient is supplied as a medicated nail lacquer, a specialized dosage form designed for localized, transungual application to the affected nail surface. The unique formulation includes excipients such as ethanol and a film-forming polymer to create a persistent layer, ensuring that the active substance is delivered into the dense keratin structure of the nail.


How Does Amorolfine Target Fungal Infections?

Amorolfine functions by severely impairing the integrity of the fungal cell membrane, which provides its fungicidal (cell-killing) and fungistatic (growth-stopping) effects. This disruption is achieved by inhibiting two key fungal enzymes essential for the biosynthesis of the crucial membrane component, Ergosterol. This dual-action mechanism is clinically recognized for its effectiveness against a variety of pathogenic fungi. By preventing the production of Ergosterol, the medicine fundamentally disrupts the fungal organism's ability to survive and multiply, targeting the infection at a structural level.

What side effects are possible with Curanail?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety restrictions for Curanail (amorolfine 5% medicated nail lacquer), based strictly on authoritative regulatory documents.

Adverse Reactions by Frequency

Most documented side effects are local and infrequent.

Frequency Category Adverse Reactions
Rare (1 in 1,000 to 1 in 10,000 users) Nail disorders (e.g., brittle nails, discoloration, broken nails)
Very Rare (less than 1 in 10,000 users) Skin burning sensation at the application site
Frequency Not Known (cannot be estimated from available data) Systemic allergic reactions (hypersensitivity), erythema, pruritus, contact dermatitis, urticaria, blisters

Serious Adverse Reactions

Systemic allergic reactions are serious and require immediate medical attention if they occur. Symptoms may include swelling of the face, lips, tongue, or throat, difficulty breathing, and/or a severe, widespread skin rash or hives. The product must be immediately removed and discontinued if a systemic allergic reaction is suspected.

Safety Restrictions and Limitations

  • Contraindication: Curanail must not be used by patients with a known hypersensitivity or allergy to the active substance (amorolfine) or any of the excipients in the lacquer.
  • Population Specifics: Use is not recommended in children under 18 years due to a lack of sufficient clinical experience and safety data in this age group. Use is also not recommended during pregnancy or breast-feeding as the potential risk is unknown due to limited data.
  • Excipient Warning: The lacquer contains a high percentage of ethanol (alcohol), which is a flammable substance. The product should be kept away from heat, open flame, and lit cigarettes during application and drying. The ethanol content may also cause a temporary burning sensation on damaged skin.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Amorolfine 5% Medicated Nail Lacquer defines the overdose risk primarily around accidental exposure, rather than excessive topical use.

Feature Official Regulatory Statement
Documented overdose presentations No systemic signs of overdose are expected following topical application due to the negligible systemic absorption of Amorolfine.
Physiological systems affected (as stated in label) None documented specifically for topical overdose; the hazard relates to the potential effects of accidental ingestion.
Dose-related or exposure-related factors (if applicable) The primary risk factor requiring action is the accidental oral ingestion of the nail lacquer product.
Population-specific overdose notes (if applicable) Children are the main population of concern for accidental oral ingestion, which mandates immediate attention.
Emergency-response statements (as written in official documents) Treatment for accidental ingestion should be symptomatic and supportive.
When immediate medical help is required (label-derived phrasing only) Urgent medical attention must be sought immediately if the nail lacquer is accidentally swallowed.

Overdose classifications (high-level)

Classification Aspect Regulatory Description
Severity classification (as defined in official documents) Systemic overdose resulting from topical use is classified as unlikely.
Regulatory basis (EMA / FDA / etc.) Information is based on official prescribing documents and regulatory safety profiles.
Overdose-context constraints (as defined in official documents) No specific antidote is known for Amorolfine overdose.

Resulting overdose structure

Official overdose statements:

  • Overdose resulting from the topical use of the nail lacquer is not expected due to the low systemic absorption of Amorolfine.
  • The regulatory mandate for emergency action is restricted to cases of accidental oral ingestion of the product.
  • For accidental oral ingestion, appropriate symptomatic measures should be taken as no specific antidote is available.

Connection to the overall overdose profile: Official regulatory documents define the product's overdose profile by stating that systemic signs are not anticipated from its intended application. The requirement to seek immediate medical attention is a specific directive triggered by accidental ingestion, which necessitates supportive management and may require hospital monitoring. This structure reflects the regulatory focus on low-risk topical agents and specific accidental exposures.

Therapeutic Uses of Curanail

What Curanail Treats: Main Uses and Therapeutic Benefits

Curanail (Amorolfine) is a localized topical antifungal medication whose primary therapeutic purpose is the management of onychomycosis, the fungal infection of the nail plate. As an official indication, Curanail is used for the treatment of mild cases of distal and lateral subungual onychomycoses limited up to 2 nails. The treatment is generally applied to cases of mild to moderate severity where the infection is localized to the nail tip or sides.

This medication is applied in addressing the active fungal growth, supporting the overall symptomatic management of the condition. It is relevant for easing the progression of the condition and contributes to improved comfort during difficult episodes while assisting with maintaining functional stability when symptoms involve potential spread. The core therapeutic focus is on specific symptoms, including nail discoloration, structural thickening (dystrophy), and brittleness.

“The goal of this focused treatment is to help manage the infection and support the process of nail regeneration.”

The treatment supports the process of nail regrowth, providing supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Nail Dystrophy Curanail is commonly used to help manage symptoms related to Aesthetic and Structural Nail Degradation, supporting the patient during symptomatic periods by easing the impact of visual and structural damage.


Eligibility and Restrictions for Use

Who Can and Cannot Use Curanail?

Curanail (Amorolfine 5% Nail Lacquer) eligibility is strictly defined by regulatory documentation. The medication is contraindicated for patients with known hypersensitivity to the active substance, amorolfine, or any of its excipients.

Population Eligibility and Restrictions

Classification Rule/Restriction
Approved Use Adults (18 years and older) with mild cases of onychomycosis.
Infection Scope Limited to infection covering up to 2 nails and affecting less than two-thirds of the nail plate.
Not Recommended Children and adolescents (under 18 years) due to a lack of sufficient clinical experience.
Physiological Status Use is not recommended during pregnancy or breastfeeding due to limited clinical data.

Conditional Use Requirements

Patients with diabetes mellitus, peripheral vascular diseases (poor circulation), or immune system disorders must seek medical determination before commencing treatment. These conditions necessitate professional assessment to ensure appropriate care and rule out the need for systemic treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Curanail (Amorolfine 5% nail lacquer) is a topical medicine whose interaction profile is defined by its low systemic absorption and localized application restrictions, according to official regulatory documents.

Absence of Systemic Interactions

Official regulatory information states that no formal interaction studies have been performed to assess systemic interactions between Amorolfine and other medicines. Consequently, there are no documented metabolic, pharmacokinetic, or pharmacodynamic drug-drug interactions, nor are any combinations listed as formally contraindicated due to systemic risk. This reflects the highly localized nature of the medicine's application.

Product and Substance Restrictions

The documented interaction constraints are related to the maintenance of the lacquer film on the nail surface:

  • Cosmetic Products: The application of cosmetic nail varnish is restricted by a mandatory timing rule, requiring a minimum separation of 10 minutes after Curanail has been applied.
  • Artificial Nails: The regulatory label explicitly requires that the use of artificial nails must be avoided during the treatment period.
  • Organic Solvents: A procedural constraint mandates that impermeable gloves must be worn when working with specific organic solvents (such as paint thinners or white spirit). This measure is required to prevent the physical removal of the medicated lacquer layer from the nail.

Mechanism of Action

The active substance, Amorolfine, is an antifungal agent that operates via a highly specific molecular mechanism to disrupt the structure and viability of fungal organisms. This action is confined to the fungal cell, resulting in its elimination from the affected tissue.

Targeted Inhibition of Fungal Enzyme Systems

The mechanism involves the precise, dual inhibition of two critical enzymes within the fungal sterol synthesis pathway: Delta14-reductase and Delta7-Delta8-isomerase. By blocking these enzymes, Amorolfine disrupts the biochemical sequence required for the fungus to produce its structural components.

Degradation of the Fungal Cell Membrane

This enzyme blockade leads to a profound depletion of Ergosterol—the necessary sterol for cell membrane stability—and the simultaneous accumulation of abnormal, non-functional sterols (primarily Ignosterol) . This structural compromise severely weakens the fungal cell membrane, leading to increased permeability and loss of internal contents.

Fungicidal and Fungistatic Effects

The loss of cell membrane integrity triggers a decisive cascade that results in the killing of the fungal organism (fungicidal effect) and the cessation of its growth and multiplication (fungistatic effect). This sustained, localized physiological action supports the cessation of fungal proliferation within the affected nail structure.

Dosage and Administration Information

How Curanail is Used: Official Administration Guidelines

Curanail is a 5% w/v medicated nail lacquer that is strictly intended for topical use and application to the surface of the affected fingernails and toenails. The official administration pattern is a once weekly application to all affected nails, although a twice-weekly application may be utilized in certain clinical contexts.

Procedural Requirements

The established usage protocol requires specific steps before each new application to ensure effective drug delivery. The affected areas of the nail must first be filed down thoroughly, and the surface must then be cleansed and degreased using a cleaning swab. Any remaining lacquer from the previous application must be completely removed before reapplying the dose. To prevent the transmission of the fungal growth, nail files used on infected nails must not be reused on healthy nails. Additionally, patients using organic solvents are instructed to wear impermeable gloves to protect the applied lacquer.

Duration and Specific Populations

Treatment with Curanail is structured as a long-term plan and must continue without interruption until the nail is fully regenerated. The typical duration of use is approximately six months for fingernails and generally ranges from nine to twelve months for toenails. While approved for use in the adult population, the medicine is not recommended for patients under 18 years due to limited clinical experience in this age group. Treatment progress is formally reviewed at three-month intervals to assess the need for continued therapy.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Curanail

Evidence for Mild to Moderate Onychomycosis (Fungal Nail Infection)

Research has explored the use of Amorolfine nail lacquer as a stand-alone treatment for fungal nail infections that are limited in extent. These investigations primarily used randomized controlled trials (RCTs) and comprehensive meta-analyses to study adult patients. Outcomes recorded included Mycological Cure (laboratory confirmation that the fungal presence has been measured as eliminated) and Clinical Cure (the visible appearance of the nail).

Studies documented measurements of both physical appearance and fungal presence over follow-up periods often ranging from six months to over a year. Findings indicate that the medicine was associated with patterns of both mycological and clinical clearance in the populations studied. However, evidence quality varies across some trials, and there is limited information for long-term outcomes beyond the first 18 months of study follow-up.

Research on Combination Therapy for Severe Onychomycosis

Studies also explored using Amorolfine nail lacquer in conjunction with oral antifungal agents, mainly evaluated in patients with more extensive or severe fungal nail infections. Research monitored the combined treatment's ability to measure the Complete Cure outcome (requiring both fungal elimination and visual clearance).

Studies documented measurements of the Complete Cure rates, and findings show patterns related to the combined approach. Comparative evidence is lacking to fully determine the patient profile that benefits most. Research is ongoing regarding the optimal duration of application within a combined regimen.

Understanding Research Gaps and Limitations

The overall evidence base highlights certain areas where certainty remains low. Data for certain groups remain insufficient, notably the pediatric population (children). Additionally, follow-up durations were limited in some studies, and comparative evidence is lacking concerning head-to-head comparisons against every currently available topical treatment. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Curanail (FAQ)


Q: Does Curanail actually kill the fungus or just stop it from growing?

A: According to the official product information, the active ingredient, amorolfine, has a dual action against the fungal organism. This means it works by both killing the fungus (a fungicidal effect) and stopping its growth and multiplication (a fungistatic effect). This combined mechanism is documented to target the fungal proliferation within the affected nail tissue.

Q: Can I wear cosmetic nail polish on top of Curanail?

A: Yes, cosmetic nail varnish can be used during treatment. However, the product label specifies that one should wait at least 10 minutes after Curanail has dried before applying the cosmetic polish. It is important to note that the use of artificial nails must be avoided during the entire treatment period.

Q: What should be done if the lacquer gets into the eyes or mouth?

A: If the lacquer accidentally gets into the eyes or ears, the area should be washed out with water immediately, and medical advice should be sought. If the medicine is accidentally swallowed, medical advice should be sought, or contact the nearest hospital straight away, as the product is only intended for external topical use.

Q: Why must one wear impermeable gloves when handling organic solvents like paint stripper while using Curanail?

A: Procedural constraints require the use of impermeable gloves when working with organic solvents, such as paint thinners or white spirit. This measure is needed to protect the medicated lacquer layer on the nail surface. Organic solvents may physically remove the Curanail layer, compromising the effectiveness of the treatment.

Q: Is Curanail effective against all types of nail fungus?

A: Official information indicates that Amorolfine is active against the main causative agents of fungal nail infections. These include specific groups of pathogens such as dermatophytes, yeasts, and moulds. The active substance is documented to be effective against the main fungal groups that cause nail infections.

Q: Is it normal to not see visible improvement during the first two months of using Curanail?

A: Nails grow slowly, and it often takes an extended period for the healthy, untreated nail to grow out. For this reason, official treatment guidelines state that it may take 2 to 3 months of continuous treatment before any visible improvement in the appearance of the nail is seen. The long treatment duration reflects the slow process of nail regeneration.

Q: What should I use to clean the nail if I run out of the provided swabs?

A: The regulatory procedure for application states that the nail surface must be cleansed and degreased to remove any remaining old lacquer and filing debris. Official product information notes that the nail surface can be cleansed with an alcohol-soaked swab for this purpose.

Q: What is the correct way to dispose of the used nail files and cleaning swabs?

A: Used cleaning swabs should be carefully discarded as they are flammable due to the product's ethanol content. Disposal of all waste material must follow local waste disposal requirements, and items should not be put into general household waste.

Q: Can I reuse the applicator, and how should it be cleaned?

A: The applicator provided with the product is re-usable. It is important that the applicator is cleaned after each use to prevent cross-contamination. The cleaning should be done using the same cleaning swab that was used to clean the nail surface.

Q: What happens if Curanail accidentally touches the skin around the nail?

A: Official warnings state that Curanail should not be applied to the skin around the nail. The product contains alcohol (ethanol), and its inappropriate application may cause irritation or dryness of the surrounding skin. If contact occurs or symptoms develop, consultation with a healthcare professional is recommended.

Q: Can Curanail cause the skin around the nail to become red or irritated?

A: Side effects that affect the skin around the application site have been reported. These include local reactions such as pruritus (itching), erythema (redness), and general irritation or dryness of the surrounding skin. These reactions are typically infrequent and local to the application site.

Q: What should be done if the infection appears to be worsening despite consistent application?

A: The progress of the treatment should be checked every three months. If the infection appears to be the same or worsening after this assessment, consultation with a doctor or pharmacist is required for a professional determination. This ensures the treatment regimen remains appropriate for the extent of the infection.

Q: Are there any known interactions between Curanail and common oral medications?

A: Official regulatory documents confirm that Curanail has no documented systemic drug-drug interactions with oral medications. This is due to the medicine's highly localized topical application and very low absorption into the bloodstream. Therefore, the medicine can normally be used when taking other oral medications.

Q: What are the main signs or symptoms of a fungal nail infection that Curanail is meant to treat?

A: Curanail is intended to treat fungal nail infections, which typically result in the nail becoming discoloured (white, yellow, or brown). The affected nail may also appear thick, brittle, or crumbly. These visual signs indicate the presence of the fungal growth in the nail keratin structure.

Q: If I miss an application of Curanail, what is the recommended procedure?

A: There is no cause for immediate concern if an application is missed. The next application should be made as soon as it is remembered, following the usual steps (filing, cleansing, and application). The long-term success of the treatment depends on continuous, uninterrupted use over the full duration.

Q: How can I keep track of the progress of the infection clearing up?

A: Progress is primarily monitored by observing the growth of a new, healthy nail starting from the base. Treatment progress is formally reviewed through consultation with a doctor or pharmacist at intervals of approximately three months to assess the new nail growth and the clearance of the infected area.

Q: Can the fungal infection return after a course of Curanail treatment is finished?

A: Onychomycosis (fungal nail infection) is a condition generally noted for high recurrence rates even after successful treatment. Preventative hygiene measures are often suggested to help reduce the likelihood of re-infection after treatment is complete.

Q: Is it true that fungal nail infections are often linked to athlete's foot?

A: Yes, the regulatory guidance advises that fungal infections of the nail and the skin of the foot (Tinea pedis or Athlete's foot) are often linked. If co-existent Tinea pedis is present, it should also be treated with an appropriate anti-fungal cream to prevent reinfection of the nail.

Q: How is Curanail affected by high temperatures or exposure to heat?

A: Curanail must be stored below 30 C and protected from heat. The bottle must also be kept tightly closed immediately after use. These precautions are necessary because the product contains ethanol, and exposure to heat may cause the product to evaporate or lose stability.

Q: What happens to the Curanail if it passes its expiration date?

A: Official regulatory documents strictly mandate that the product must not be used after the expiry date shown on the carton and bottle. Past this date, the integrity, quality, and efficacy of the product cannot be guaranteed, and it may not work as intended.

Q: What kind of doctor or specialist typically prescribes or recommends Curanail?

A: Consultation with a doctor or pharmacist is required for a professional assessment, advice on suitability, and to commence treatment with Curanail. These healthcare professionals are also the appropriate points of contact to review the treatment progress and provide guidance.

Q: Can the chemicals in normal nail varnish remover affect the Curanail treatment?

A: Yes, substances commonly found in nail varnish removers are organic solvents and will remove the lacquer layer from the nail. This is why any existing nail varnish must be removed before each new application of Curanail is applied.

Q: Is it possible to develop an allergy to Curanail after using it for a long time?

A: Like all medicines, Curanail can cause allergic reactions (hypersensitivity), although they are generally rare. If an allergic reaction is suspected, the product should be immediately removed from the nail, and medical advice should be sought, as some reactions can be serious.

Q: Is there a risk of spreading the nail infection when filing the nail?

A: Yes, there is a documented risk of spreading the infection if nail files used on the infected nail are reused on healthy nails. The procedural instruction to use separate or disposable files is intended specifically to prevent this form of transmission.

Q: Does Curanail help if the nail is already separating from the nail bed (onycholysis)?

A: Curanail is generally intended for mild infections affecting less than two-thirds of the nail plate. If the nail is severely damaged (such as separation from the nail bed, known as onycholysis), consultation with a doctor is necessary, as combined treatment options, such as oral therapy in combination with the lacquer, may be indicated.

Q: Why does the application method for Curanail involve cleaning the applicator with the same swab?

A: The application procedure requires using the same swab to ensure the applicator is thoroughly cleaned and ready for the next use. This step is also mandated to prevent the user from accidentally touching the newly treated nail with a used swab, which could spread the infection or disrupt the fresh lacquer layer.

Q: Is the product intended to be colorless and invisible when dry?

A: Yes, the Amorolfine nail lacquer is described in official documents as a clear, colourless solution. The specialized formulation is designed to dry clear on the nail, delivering the active ingredient locally without adding color or opacity.

Q: Is there any information on how long a single bottle of Curanail typically lasts?

A: The product’s shelf life after the first opening is 6 months. The product is used once weekly, and the pack size is generally intended to cover the required treatment duration (which typically ranges from 6 to 12 months).

How should Curanail be stored and disposed of?

Storage and Disposal Instructions for Curanail

Curanail (Amorolfine Nail Lacquer) must be stored and handled according to specific regulatory conditions to maintain its integrity and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store below 30 C and protect from heat.
Protection Keep the bottle tightly closed immediately after use.
Child Safety Mandatory to keep out of the sight and reach of children.
Handling Avoid using near an open flame or lit cigarette, as the lacquer is a flammable substance due to its ethanol content.

Disposal

Unused or expired medicine must not be disposed of via wastewater or household waste. All disposal must be done in accordance with local waste disposal requirements, typically through a pharmacy or authorized collection point. Do not use the product after the stated expiry date.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Curanail found in:

A-Z Index: